Webcast/CME - Incretin-Related Therapies: Targeting the Underlying Physiology and Cardiometabolic Factors of Type 2 Diabetes

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Obesity

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Obesity

	Obesity Management in Patients with Type 2 Diabetes
	Vitamin Deficiency After Gastric Bypass Surgery: A Review
	The Evolution of Cardiometabolic Risk Reduction and Mixed Dyslipidemia: Examining the Role of Chronic Obesity Management
	Issues in Cardiovascular & Metabolic Risk Management: Highlights from ENDO 08

Recent news - Obesity

	TopAbstracts in Obesity 11/24/2009 - (DGNews)
	Study Finds Prevalence of Barrett's Oesophagus in Asymptomatic Women - (DGNews)
	FDA Investigates Risk of Cardiovascular Events in Patients Using Sibutramine - (DGNews)
	Benefits of Bariatric Surgery in Adolescents Persist After 2 Years: Presented at AHA - (DGDispatch)
	Smoking and Obesity Are Major Risk Factors for Thromboembolic Events: Presented at AHA - (DGDispatch)

Recent cases - Obesity

	Obesity
	How 40 Kilograms of Fluid Retention Can be Overlooked: Two Case Reports
	Reconstruction of the Gastric Passage by a Side-To-Side Gastrogastrostomy After Failed Vertical-Banded Gastroplasty: A Case Report
	Perforated Appendicitis Masquerading as Acute Pancreatitis in a Morbidly Obese Patient.
	Giant Serous Cystadenoma Arising from an Accessory Ovary in a Morbidly Obese 11-Year-Old Girl: A Case Report

personal edition > obesity > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Incretin-Related Therapies: Targeting the Underlying Physiology and Cardiometabolic Factors of Type 2 Diabetes

Presented by:	DIME
Lecturer	Frank Lavernia, MD, Joseph Largay, PA -C, CDE and Terry Ridge, DNP (c), ANP -BC , BC -ADM , CDE
Approximate duration:	1.25 hrs.
Summary points:	In this accredited journal supplement, participants will learn about the role of incretin hormones in type 2 diabetes, the advantages and disadvantages of available and emerging incretin-related therapies, and treatment approaches that go beyond glycaemic control to manage obesity and prevent long-term microvascular and macrovascular complications.
Accreditation:	DIME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DIME designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s). Expiration date: February 6, 2010.
Other:	Text-only CME.

Additional Information